Cargando…
Role of ctDNA for the detection of minimal residual disease in resected non-small cell lung cancer: a systematic review
BACKGROUND: Operable stage I-III non-small cell lung cancer (NSCLC) has a high risk of recurrence, mainly due to remnant clones of the disease defined as minimal residual disease (MRD). Adjuvant chemotherapy has a limited efficacy in reducing the risk of relapse, and prognostic as well as predictive...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830273/ https://www.ncbi.nlm.nih.gov/pubmed/36636413 http://dx.doi.org/10.21037/tlcr-22-390 |